4Asanuma K, Mundel P. The role of podocytes in glomerular pathobiology. Clin Exp Nephrol, 2003,7 (4) : 255 - 259.
5Doyonnas R, Kershaw DB,Duhme C, et al. Anuria, omphalocele, and perinatal lethality in mice lacking the CD34 - related protein podocalyxin. J Exp Med, 2001,194( 1 ) : 13 - 27.
6Cybulsky AV, Carbonetto S, Huang Q, et al. Adhesion of rat glomerular epithelial ceils to extracellular matrices: role of β1 integrins. Kidney Int, 1992,42(5) : 1099 - 1106.
7Korhonen M, Ylanne J, Laitinen L, et al. The α1 - α6 subunits of integrins are characteristically expressed in distinct segments of developing and adult human nephron. J Cell Biol, 1990,111 (3) : 1245 - 1254.
8Kreidberg JA, Donovan M J, Goldstein SL, et al. α3β1 integrin has a crucial role in kidney and lung organogenesis. Development, 1996,122 (11 ) : 3537 - 3547.
9Adler S,Sharma R, ,Savin VJ, et al. Alteration of glomerular permeability to macromolecules induced by cross-linking of β1 integrin receptors. Am J Pathol, 1996,149(3) :987 - 996.
10Raats CJ,van den Born J, Bakker MA, et al. Expression of agrin, dystroglycan and utrophin in normal renal tissue and in experimental glomerulopathies. Am J Pathol, 2000, 156(5) : 1749 - 1765.
2Ahren B, Landin-Olsson M, Jansson PA, et al. Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes. Clin Endocrinol Metab, 2004, 89(5): 2078-2084
3Zimmet P,Shaw J, Albertit KG. Preventing type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view. Diabet Med, 2003, 20(9): 693-702
4Wiseman, Alexander, Ronald. Current status of clinical islet transplantation: advances and obstacles. Curr Opin Endocrinol Diabetes, 2004, 11(2): 98-103
5Zhang Y, Atkinson. Gene therapy for type 1 diabetes: metabolism, immunity, islet cell preservation, and regeneration. Curr Opin Endocrinol Diabetes, 2004, 11(2): 91-97
6Bloomgarden ZT. Type 2 diabetes in the young. Diabetes Care, 2004, 27(4): 998-1010
7Engelgau MM. Diabetes diagnostic criteria and impaired Glycemic states: evolving evidence base. Clin Diabetes, 2004, 22(2): 69-70
8Gura T. Diabetes research: new lead found to a possible ""insulin pill"". Science, 1999, 284(5416): 886
9Barnett AH. A review of basal insulins. Diabet Med, 2003, 20(11): 873-885
10Cefalu WT. Concept, strategies, and feasibility of noninvasive insulin delivery. Diabetes Care, 2004, 27(1): 239-246
7Ghosh J, Weiss MB, Kay RH, et al. Diabetes mellitus and coronary artery disease : therapeutic considerations [J].Heart Dis,2003,5 ( 2 ) : 119.
8Gokce N, Keaney JF, Hunter LM, et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study[J]. Circulation, 2002, 105 (13) :1567.
9Coward,RJM,Foster RR,Patton D,et al.Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin,podocin,and CD2 associated protein in cultured human podocytes[J].J Am Soc Nephrol,2005,16:629-637.
10McNagny KM,Petterson I,Rossi F.Thrombomucin,a novel cell surface protein that defines thrombocytes and multipotent hematopoietic progenitors[J].J Cell Biol,1997,138:1395-1407.
